Review
Published on 30 Apr 2024
Natural products for managing metabolic syndrome: a scoping review
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1366946
- 102 views
Volumes
22,464 Publications
Volume 15 - 2024
Mini Review
Published on 30 Apr 2024
Past and future of an IMI-PharmaTrain (IMI-PhT)-initiated multinational pharmaceutical medicine course at the Semmelweis University in Hungary
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1394987
Original Research
Published on 30 Apr 2024
Qualitative and quantitative analysis methods for quality control of rhubarb in Taiwan’s markets
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1364460
- 132 views
Review
Published on 30 Apr 2024
Codonopsis radix: a review of resource utilisation, postharvest processing, quality assessment, and its polysaccharide composition
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1366556
Original Research
Published on 30 Apr 2024
Apigenin protects against ischemic stroke by increasing DNA repair
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362301
Review
Accepted on 29 Apr 2024
A Detailed Overview of Quercetin: Implications for Cell Death and Liver Fibrosis Mechanisms
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389179
Review
Accepted on 29 Apr 2024
Chinese Botanical Drugs Targeting Mitophagy to Alleviate Diabetic Kidney Disease, a Comprehensive Review
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1360179
Mini Review
Accepted on 29 Apr 2024
Mini-Review: Insights into the Voltage-gated Sodium Channel, NaV1.8, and Its Role in Visceral Pain Perception
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1398409
Original Research
Accepted on 29 Apr 2024
Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1372401
Review
Accepted on 29 Apr 2024
The structure and function of FUN14 domain-containing protein 1 and its contribution to cardioprotection by mediating mitophagy
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389953
Original Research
Accepted on 29 Apr 2024
Identification and validation of a platelet-related signature for predicting survival and drug sensitivity in multiple myeloma
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377370
Original Research
Accepted on 29 Apr 2024
Investigating Sulforaphane's Anti-Virulence and Anti-Quorum Sensing Properties Against Pseudomonas aeruginosa
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1406653
Opinion
Accepted on 29 Apr 2024
Quadruplet Regimen for Newly Diagnosed Multiple Myeloma Is Effective in the Standard-Risk Subgroup but Not in the High-Risk Subgroup
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1398879
Original Research
Accepted on 29 Apr 2024
Combination of Plant Metabolites Exerts Compatibly Hindering Starch Digestion and Glucose Absorption with Facilitating Insulin Sensitivity Towards Diabetes Subtitle: Synergy of metabolites abrogates hyperglycemia
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362150
Original Research
Accepted on 29 Apr 2024
Establishment of a human nasal epithelium model of histamineinduced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1393702
Review
Accepted on 29 Apr 2024
Emerging Biologic Frontiers for Sjogren's Syndrome: Unveiling Novel Approaches with Emphasis on Extra Glandular Pathology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377055